Intercept Pharmaceuticals Inc (ICPT)
27.45
-1.79 -6.12%
NASDAQ
Jan 15, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 300.92M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -9.78 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -320.89M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 97.70% |
| Profit Margin (Quarterly) | -83.59% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 905.64M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 2.994 |
| PE Ratio | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -4.246 |
| Free Cash Flow (Quarterly) | -41.81M |
| Return on Equity | Upgrade |
View All ICPT News
News
-
WireHeadlineTime (ET)
-
MT Newswires01/15 16:39
-
SA Breaking News01/15 10:23
-
MT Newswires01/15 08:25
-
MT Newswires01/13 10:10
-
Globe Newswire01/11 08:00
-
SA Breaking News01/07 17:50
-
MT Newswires01/05 11:48
-
Globe Newswire01/05 08:00
-
Yahoo01/04 12:45
-
Yahoo01/04 11:53
-
Yahoo01/04 11:45
-
Yahoo01/04 11:12
-
Yahoo01/04 09:47
-
PR Newswire01/04 09:47
-
Yahoo01/04 09:31
-
Yahoo01/04 09:15
-
PR Newswire01/04 08:30
-
Yahoo01/04 06:20
-
Yahoo01/03 23:45
-
Yahoo01/03 12:10
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 02/25/2021 | Earnings | Intercept Pharmaceuticals Inc Fourth Quarter Earnings for 2020 Release |
| 02/25/2021 08:30 EST | Misc | Intercept Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2020 |
| 11/09/2020 | Earnings | Intercept Pharmaceuticals Inc Third Quarter Earnings Result for 2020 |
| 11/09/2020 08:30 EST | Misc | Intercept Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020 |
| 08/10/2020 08:30 EDT | Misc | Intercept Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020 |
| 08/10/2020 | Earnings | Intercept Pharmaceuticals Inc Second Quarter Earnings Result for 2020 |
| 05/28/2020 10:00 EDT | Misc | Intercept Pharmaceuticals Inc Annual General Meeting for 2019 |
| 05/11/2020 08:30 EDT | Misc | Intercept Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020 |
| 05/11/2020 | Earnings | Intercept Pharmaceuticals Inc First Quarter Earnings Result for 2020 |
| 02/25/2020 08:30 EST | Misc | Intercept Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.interceptpharma.com
- Investor Relations URL: http://ir.interceptpharma.com/index.cfm
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: Feb. 25, 2021
- Last Earnings Release: Nov. 09, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 27.45 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| CIG4926 | CI Global Health Sciences Corp Cl Y (USD) | 5.45% |
| F000015ZK6 | ST Healthcare Innovations 10 F RE | 2.89% |
| F000013KMW | ST Healthcare Innovations 7 F RE | 1.02% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ICPT Tweets Stocktwits
Advertisement
